GGrantIndex
← Leaderboards

Todd Sulchek

Stanford University

$3,054,760
Attributed
$5,452,022
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $890.9K · FY201125
$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,452,022 · 6

By mechanism

R01$3,652,821 · 2
R21$1,799,201 · 4

Top collaborators

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Design

Research focus

DesignCellsMicrofluidicsMicrofluidic MicrochipsMolecularLabelTechnologyProteinsEngineeringRouteNanoparticlePhenotypeAffectCancer CellDevice DesignsFlow CytometryReagentCell TypeIn VitroCell SeparationBaseCell SurvivalContrast MediaDevices

Grant awards (18)

Microfluidics to explore ultrafast cell deformations to deliver large cargo via convective transport$300,833
R01 · FY2025 · GM · contact PI
New tools for tracking single cells in vivo$589,925
R01 · FY2024 · EB
Microfluidics to explore ultrafast cell deformations to deliver large cargo via convective transport$300,999
R01 · FY2024 · GM · contact PI
New tools for tracking single cells in vivo$588,962
R01 · FY2023 · EB
Microfluidics to explore ultrafast cell deformations to deliver large cargo via convective transport$300,999
R01 · FY2023 · GM · contact PI
Microfluidics to explore ultrafast cell deformations to deliver large cargo via convective transport$300,999
R01 · FY2022 · GM · contact PI
Microfluidic platforms to generate 'off-the-shelf' fratricide-resistant CAR T cells for T-cell malignancies$173,201
R21 · FY2022 · CA
New tools for tracking single cells in vivo$620,088
R01 · FY2021 · EB
Microfluidic platforms to generate 'off-the-shelf' fratricide-resistant CAR T cells for T-cell malignancies$223,162
R21 · FY2021 · CA
New tools for tracking single cells in vivo$650,016
R01 · FY2020 · EB
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid$74,153
R21 · FY2019 · CA · contact PI
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid$109,753
R21 · FY2018 · CA · contact PI
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid$187,018
R21 · FY2017 · CA · contact PI
Label-free microfluidic enrichment of cancer cells from noncancer cells in ascites fluid$222,446
R21 · FY2016 · CA · contact PI
Microfluidic Monitoring of Single Cell Elasticity, Viscoelasticity, and Plasticity$176,508
R21 · FY2016 · EB · contact PI
Microfluidic Monitoring of Single Cell Elasticity, Viscoelasticity, and Plasticity$228,095
R21 · FY2015 · EB · contact PI
Tunable affinity and heat stable antibody targeting of nanoparticles$177,322
R21 · FY2012 · EB · contact PI
Tunable affinity and heat stable antibody targeting of nanoparticles$227,543
R21 · FY2011 · EB · contact PI